Inventor · disambiguated record
Yuman Fong
Also filed as: FONG YUMAN
17 granted patents·18 pending applications·96 citations·filing 1998–2025
91Inventor score
Top patents by PatentIndex Score
35 records- 0196US8591881B2Chimeric Newcastle disease viruses and uses thereofPALESE PETER·Filed 2010·Granted Nov 26, 2013·52 cites·16 claims
- 0285US12084687B2Chimeric poxvirus compositions and uses thereofHOPE CITY·Filed 2017·Granted Sep 10, 2024·2 cites·27 claims
- 0385US9217136B2Chimeric Newcastle disease viruses and uses thereofSINAI SCHOOL MEDICINE·Filed 2013·Granted Dec 22, 2015·6 cites·14 claims
- 0484US10758632B2NIR-conjugated tumor-specific antibodies and uses thereofHOPE CITY·Filed 2018·Granted Sep 1, 2020·3 cites·14 claims
- 0584US10053660B2Substrates for high-density cell growth and metabolite exchangeCALIFORNIA INST OF TECHN·Filed 2017·Granted Aug 21, 2018·1 cites·20 claims
- 0682US2024279581A1System, device and method for production of bioproduct including high density cell respirator (hdcr) for intensified production of adeno-associated viruses (aav) and cell-based productionHOPE CITY·Filed 2024·Application pending·0 cites
- 0779US2022348856A1Substrates for High-Density Cell Growth and Metabolite ExchangeCALIFORNIA INST OF TECHN·Filed 2022·Application pending·0 cites
- 0878US2025084384A1Chimeric poxvirus compositions and uses thereofHOPE CITY·Filed 2024·Application pending·0 cites
- 0976US12178887B2NIR-conjugated tumor-specific antibodies and uses thereofHOPE CITY·Filed 2023·Granted Dec 31, 2024·0 cites·6 claims
- 1076US10035984B2Chimeric newcastle disease viruses and uses thereofICAHN SCHOOL MED MOUNT SINAI·Filed 2015·Granted Jul 31, 2018·1 cites·18 claims
- 1176US6051428ARapid production of autologous tumor vaccinesSLOAN KETTERING INST CANCER·Filed 1998·Granted Apr 18, 2000·31 cites·40 claims
- 1273US11981885B2System, device and method for production of bioproduct including high density cell respirator (HDCR) for intensified production of adeno-associated viruses (AAV) and cell-based productionHOPE CITY·Filed 2020·Granted May 14, 2024·0 cites·21 claims
- 1372US11414636B2Substrates for high-density cell growth and metabolite exchangeCALIFORNIA INST OF TECHN·Filed 2018·Granted Aug 16, 2022·0 cites·10 claims
- 1468US12391993B2Methods, treatment, and compositions for characterizing thyroid noduleHOPE CITY·Filed 2022·Granted Aug 19, 2025·0 cites·20 claims
- 1566US2025381237A1Oncolytic virus expressing a car t cell target and uses thereofHOPE CITY·Filed 2025·Application pending·0 cites
- 1665US2025146017A1Methods comprising oncolytic viruses expressing cd19t and bispecific t cell engagersHOPE CITY·Filed 2024·Application pending·0 cites
- 1762US2009117034A1Microorganisms for imaging and/or treatment of tumorsCHEN NANHAI·Filed 2008·Application pending·0 cites
- 1861US12364724B2Oncolytic virus expressing a car T cell target and uses thereofHOPE CITY·Filed 2018·Granted Jul 22, 2025·0 cites·11 claims
- 1961US2022349012A1Dna methylation diagnostic test for breast cancerHOPE CITY·Filed 2021·Application pending·0 cites
- 2060US11065032B2Lighting and optics surgical systemHOPE CITY·Filed 2019·Granted Jul 20, 2021·0 cites·15 claims
- 2160US10932817B2Lighting and optics surgical systemHOPE CITY·Filed 2019·Granted Mar 2, 2021·0 cites·10 claims
- 2258US11242568B2DNA methylation diagnostic test for breast cancerHOPE CITY·Filed 2018·Granted Feb 8, 2022·0 cites·12 claims
- 2357US2020368372A1Nir-conjugated tumor-specific antibodies and uses thereofHOPE CITY·Filed 2020·Application pending·0 cites
- 2456US2025129139A1CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING gD AND ONCOLYTIC VIRUSES FOR CANCER THERAPY AND TREATMENT OF HSVHOPE CITY·Filed 2022·Application pending·0 cites
- 2555US2003228281A1Use of mutant herpes viruses and anticancer agents in the treatment of cancerFiled 2003·Application pending·0 cites
- 2651US11505829B2Methods, treatment, and compositions for characterizing thyroid noduleHOPE CITY·Filed 2016·Granted Nov 22, 2022·0 cites·8 claims
- 2751US2004047837A1Rapid production of autologous tumor vaccinesFiled 2003·Application pending·0 cites
- 2850US2004157299A1Rapid production of autologous tumor vaccinesFiled 2003·Application pending·0 cites
- 2948US2018286521A1Peri-operative remote care monitoring systemHOPE CITY·Filed 2018·Application pending·0 cites
- 3047US11754567B2Cancer detection and ablation system and methodHOPE CITY·Filed 2019·Granted Sep 12, 2023·0 cites·17 claims
- 3147US2005255085A1Prevention of recurrence and metastasis of cancerFONG YUMAN·Filed 2003·Application pending·0 cites
- 3246US2021345962A1Remote rehabilitation systemHOPE CITY·Filed 2021·Application pending·0 cites
- 3346US2021052660A1Neural stem cell compositions including chimeric poxviruses for cancer treatmentHOPE CITY·Filed 2019·Application pending·0 cites
- 3445US2009311664A1Method for Detection of Cancer Cells Using VirusFONG YUMAN·Filed 2006·Application pending·0 cites
- 3544US2002071832A1Use of mutant herpes viruses and anticancer agents in the treatment of cancerFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yuman Fong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →